J&J Could Explore Potential $2B Sale of Sterilization Products Division Post author:Sam Post published:February 19, 2018 Post category:BioPharma Life sciences giant Johnson & Johnson may be shopping around its sterilization products division. Source: BioSpace You Might Also Like Daiichi Sankyo Shutters Yet Another R&D Facility February 9, 2017 <b>Feldan Therapeutics</b> Announces Issuance Of First Patent For Its Peptide-Based Protein Delivery Technology, The Feldan Shuttle August 22, 2017 Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study July 30, 2017
<b>Feldan Therapeutics</b> Announces Issuance Of First Patent For Its Peptide-Based Protein Delivery Technology, The Feldan Shuttle August 22, 2017
Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study July 30, 2017